Immune diagnosis of paraneoplastic neurological disease

Clin Neurol Neurosurg. 1995 Feb;97(1):71-81. doi: 10.1016/0303-8467(95)00007-7.

Abstract

A continuous stream of new information on clinical, pathological and immunological aspects of paraneoplastic neurological syndromes has been published in recent years. In this survey, we will discuss current opinions on the value of anti-neuronal antibody detection for establishing a diagnosis of one of the paraneoplastic syndromes of the central nervous system.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Autoantibodies / blood*
  • Autoantigens / immunology*
  • Autoimmune Diseases / diagnosis*
  • Autoimmune Diseases / immunology
  • Cerebellar Diseases / diagnosis
  • Cerebellar Diseases / immunology
  • ELAV Proteins
  • Encephalomyelitis / diagnosis
  • Encephalomyelitis / immunology
  • Humans
  • Myoclonus / diagnosis
  • Myoclonus / immunology
  • Nerve Degeneration / immunology
  • Nerve Tissue Proteins*
  • Nervous System Diseases / diagnosis*
  • Nervous System Diseases / immunology
  • Ocular Motility Disorders / diagnosis
  • Ocular Motility Disorders / immunology
  • Paraneoplastic Syndromes / diagnosis*
  • Paraneoplastic Syndromes / immunology
  • RNA-Binding Proteins / immunology
  • Sensation Disorders / diagnosis
  • Sensation Disorders / immunology

Substances

  • Autoantibodies
  • Autoantigens
  • ELAV Proteins
  • Nerve Tissue Proteins
  • RNA-Binding Proteins